Security Snapshot

Edwards Lifesciences Corp - Common Stock (EW) Institutional Ownership

CUSIP: 28176E108

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

1,111

Shares (Excl. Options)

346.03MFull value: 346,030,317 · shares · 30 Sep 2026

Price

$86.32

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.02%
Share change
-64,536
Value change
-$35,467,811
Number of holders
1,111
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
576,625,106
SEC-reported price per share
$91.78
Insider filing price
$91.78
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • EW - Edwards Lifesciences Corp - Common Stock is tracked under CUSIP 28176E108.
  • 1111 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1,336 to 1,111 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $47.1BFull value: $47,103,504,928 · USD · 30 Jun 2026
    to
    $29.87BFull value: $29,865,940,867 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1111 institutions filings for Q3 2026.

Open SEC evidence

Security key

28176E108

13F reference period

Q3 2026

13F holders

1,111

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
EW
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% $3,442,673,832 44,267,376 BlackRock, Inc. 30 Sep 2025
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $3,481,680,843 43,477,533 Vanguard Capital Management 31 Mar 2026
WELLINGTON MANAGEMENT GROUP LLP 3.4% $1,547,456,998 19,826,483 Wellington Management Group LLP 30 Jun 2025
As of 30 Sep 2026, 1,111 institutional investors reported holding
346.03MFull value: 346,030,317 · shares · 30 Sep 2026
shares of Edwards Lifesciences Corp - Common Stock (EW). This represents 60% of the company’s total
576.63MFull value: 576,625,106 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
38%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 37,717,944 0.07% $3,255,812,926
STATE STREET CORP 4.6% 26,546,099 0.07% $2,291,459,266
VANGUARD PORTFOLIO MANAGEMENT LLC 4.6% 26,483,306 0.1% $2,286,038,974
WELLINGTON MANAGEMENT GROUP LLP 2.9% 16,876,681 0.26% $1,456,795,104
GEODE CAPITAL MANAGEMENT, LLC 2.7% 15,605,804 0.07% $1,341,765,563
Ninety One UK Ltd 2.1% 11,943,675 2.3% $1,030,978,043
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 1.9% 10,700,967 0.7% $923,708,338
ALLIANCEBERNSTEIN L.P. 1.3% 7,557,934 0.2% $652,880,365
BROWN ADVISORY INC 1.1% 6,456,432 0.87% $557,319,214
BANK OF AMERICA CORP /DE/ 1.1% 6,107,593 0.03% $527,207,466
Artisan Partners Limited Partnership 1.1% 6,089,932 0.97% $525,685,870
GOLDMAN SACHS GROUP INC 0.94% 5,400,474 0.05% $466,168,925
Invesco Ltd. 0.89% 5,137,242 0.03% $443,446,732
Legal & General Group Plc 0.72% 4,142,106 0.07% $357,546,594
DIMENSIONAL FUND ADVISORS LP 0.65% 3,730,309 0.06% $322,039,687
PRIMECAP MANAGEMENT CO/CA/ 0.62% 3,583,971 0.19% $309,368,377
NEUBERGER BERMAN GROUP LLC 0.61% 3,533,413 0.21% $305,158,676
VANGUARD FIDUCIARY TRUST CO 0.56% 3,253,053 0.06% $280,803,535
Holocene Advisors, LP 0.55% 3,144,457 0.65% $271,429,528
Assenagon Asset Management S.A. 0.47% 2,719,271 0.24% $234,727,473
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 0.46% 2,628,524 0.37% $226,726,457
RAYMOND JAMES FINANCIAL INC 0.44% 2,538,253 0.06% $219,101,974
Mirova US LLC 0.41% 2,376,276 2.2% $205,120,144
Woodline Partners LP 0.34% 1,988,662 0.52% $171,661,304
BAILLIE GIFFORD & CO 0.3% 1,740,553 0.14% $150,244,534

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 346,030,317 $29,865,940,867 -$35,467,811 $86.32 1,111
2026 Q2 521,899,219 $47,103,504,928 +$1,546,860,474 $90.46 1,336
2026 Q1 504,564,421 $40,396,067,556 -$214,327,669 $80.08 1,292
2025 Q4 505,032,444 $43,057,938,746 +$1,136,638,735 $85.25 1,310
2025 Q3 491,131,608 $38,168,380,487 -$829,500,443 $77.77 1,246
2025 Q2 501,621,113 $39,209,886,931 +$342,426,537 $78.21 1,244
2025 Q1 498,551,233 $36,115,652,063 -$465,368,232 $72.48 1,190
2024 Q4 502,121,728 $37,169,453,852 +$1,434,005,846 $74.03 1,216
2024 Q3 476,335,956 $31,445,076,186 -$1,421,509,048 $65.99 1,173
2024 Q2 490,550,647 $45,304,945,713 +$713,718,504 $92.37 1,277
2024 Q1 485,320,749 $46,297,731,358 +$852,078,619 $95.56 1,262
2023 Q4 477,829,932 $36,429,234,865 -$1,182,014,878 $76.25 1,238
2023 Q3 493,332,184 $34,197,715,244 -$197,281,313 $69.28 1,208
2023 Q2 494,404,816 $46,545,398,964 -$181,795,991 $94.33 1,271
2023 Q1 496,146,114 $41,039,476,936 -$928,836,476 $82.73 1,232
2022 Q4 506,466,540 $37,809,986,212 -$183,554,159 $74.61 1,211
2022 Q3 508,531,260 $42,063,615,359 -$189,784,742 $82.63 1,228
2022 Q2 508,693,121 $48,384,102,646 +$312,787,497 $95.09 1,254
2022 Q1 507,560,223 $59,693,416,781 -$872,591,871 $117.72 1,299
2021 Q4 514,695,199 $66,609,194,753 -$186,675,822 $129.55 1,305
2021 Q3 513,353,562 $58,112,410,048 +$238,109,088 $113.21 1,216
2021 Q2 511,385,312 $52,958,914,663 +$538,462,811 $103.57 1,177
2021 Q1 507,991,100 $42,491,394,444 -$423,235,938 $83.64 1,126
2020 Q4 513,938,390 $46,860,598,892 +$9,977,557 $91.23 1,145
2020 Q3 514,029,273 $41,004,174,710 +$888,569,776 $79.82 1,071
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .